Beyond Pigment Loss
Three Therapeutic Objectives in Vitiligo.
Valle Y, Lotti T, Sigova J, Parsad D
International Journal of DermatologyIn the feed 15 Sep 2026, published online 15 Sep 2026, issue 2026 Sep 15, added to PubMed 15 Sep 2026
Topics: Pigmentary disordersPhotodermatology & sun protection
Abstract
Vitiligo entails three therapeutic objectives: control of autoimmune activity, restoration of melanocyte function, and interruption of disease memory. Distinguishing these goals can refine clinical management, trial endpoints, and therapeutic development in vitiligo and other immune-mediated skin diseases.
Abstract from PubMed
PMID 42742316 · DOI 10.1111/ijd.70686